Literature DB >> 14550283

Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain.

Tsukasa Sugo1, Yuko Murakami, Yukio Shimomura, Mioko Harada, Michiko Abe, Yoshihiro Ishibashi, Chieko Kitada, Nobuyuki Miyajima, Nobuhiro Suzuki, Masaaki Mori, Masahiko Fujino.   

Abstract

Urotensin II (UII) has been reported as the most potent known vasoconstrictor. While rat and mouse orthologs of UII precursor protein have been reported, only the tentative structures of UII peptides of these animals have been demonstrated, since prepro-UII proteins lack typical processing sites for their mature peptides. In the present study, we isolated a novel peptide, UII-related peptide (URP), from the extract of the rat brain as the sole immunoreactive substance to anti-UII antibody; the amino acid sequence of the peptide was determined as ACFWKYCV. cDNAs encoding rat, mouse, and human precursor proteins for URP were cloned and revealed that the sequences of mouse and human URP peptides are the same as that for rat URP. Prepro-URP gene is expressed in several rat tissues such as those of the thymus, spleen, testis, and spinal cord, although with lower levels than the prepro-UII gene. In the human, the prepro-URP gene is expressed comparably to prepro-UII in several tissues except the spinal cord. URP was found to bind and activate the human or rat UII receptors (GPR14) and showed a hypotensive effect when administered to anesthetized rats. These results suggest that URP is the endogenous and functional ligand for UII receptor in the rat and mouse, and possibly in the human. We also describe the preparation of specific monoclonal antibodies raised against UII peptide and the establishment of a highly sensitive enzyme immunoassay system for UII peptides.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14550283     DOI: 10.1016/j.bbrc.2003.09.102

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

1.  Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis.

Authors:  Arnold S Kristof; Zhipeng You; Yin-Shan Han; Adel Giaid
Journal:  Peptides       Date:  2010-04-28       Impact factor: 3.750

2.  In vitro siRNA-mediated knockdown of the UT receptor: implications of density on the efficacy of a range of UT ligands.

Authors:  Benjamin D Hunt; Leong L Ng; David G Lambert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-06       Impact factor: 3.000

3.  Urotensin-II induces ear flushing in rats.

Authors:  J-s Qi; R Schulingkamp; T J Parry; R Colburn; D Stone; B Haertlein; L K Minor; P Andrade-Gordon; B P Damiano
Journal:  Br J Pharmacol       Date:  2007-01-08       Impact factor: 8.739

4.  Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sites.

Authors:  Brian J Holleran; Marie-Eve Beaulieu; Christophe D Proulx; Pierre Lavigne; Emanuel Escher; Richard Leduc
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

Review 5.  G protein-coupled receptor deorphanizations.

Authors:  Olivier Civelli; Rainer K Reinscheid; Yan Zhang; Zhiwei Wang; Robert Fredriksson; Helgi B Schiöth
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-09-28       Impact factor: 13.820

Review 6.  A rat brain atlas of urotensin-II receptor expression and a review of central urotensin-II effects.

Authors:  Benjamin D Hunt; Leong L Ng; David G Lambert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-04-27       Impact factor: 3.000

7.  Insights into the Molecular Determinants Involved in Urocontrin and Urocontrin A Action.

Authors:  Etienne Billard; David Chatenet
Journal:  ACS Med Chem Lett       Date:  2020-08-20       Impact factor: 4.345

8.  Discovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: insight into UII and URP receptor activation.

Authors:  D Chatenet; M Létourneau; Q T Nguyen; N D Doan; J Dupuis; A Fournier
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

9.  Behavioral effects of urotensin-II centrally administered in mice.

Authors:  Jean-Claude Do-Rego; David Chatenet; Marie-Hélène Orta; Bertrand Naudin; Camille Le Cudennec; Jérôme Leprince; Elizabeth Scalbert; Hubert Vaudry; Jean Costentin
Journal:  Psychopharmacology (Berl)       Date:  2005-10-22       Impact factor: 4.530

10.  Form-deprivation myopia in chick induces limited changes in retinal gene expression.

Authors:  Alice M McGlinn; Donald A Baldwin; John W Tobias; Murat T Budak; Tejvir S Khurana; Richard A Stone
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-08       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.